Gatorade, Frost Glacier Freeze, Cont. Neto (600 mL)
The Gatorade Puerto Rico
Product is contaminated with mold.
95,064 total recalls in our database
The Gatorade Puerto Rico
Product is contaminated with mold.
Investigation of consumer complaint found that two products had undeclared wheat as flour in an ingredient and was not listed in the ingredient statement.
Cedar Lake Tea
Organic Apricot Chai Loose Tea is being recalled due to potential glass contamination.
U.B.C. Food Distributors
UBC FOOD Distributors initiated a voluntary recall of Baraka Hot and Mild Curry Powder packed in 7 oz. plastic tubs due to high levels of lead found in the products.
The Gatorade Puerto Rico
Product is contaminated with mold.
The Gatorade Puerto Rico
Product is contaminated with mold.
The Gatorade Puerto Rico
Product is contaminated with mold.
Feast Mode Blending & Filling
Feast Mode Garlic Beer Seasoning is mislabeled as "Gluten Free"
Mylan Laboratories Limited, (Nashik FDF)
GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.
cGMP violations noted during the firm's most recent inspection.
Mylan Laboratories Limited, (Nashik FDF)
GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.
CGMP Deviations: Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.
CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product.
CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product.
Mylan Laboratories Limited, (Nashik FDF)
GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.
Mylan Pharmaceuticals
CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained in the API used to manufacture the product.
Mylan Laboratories Limited, (Nashik FDF)
GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.
Mylan Laboratories Limited, (Nashik FDF)
GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.
Mylan Pharmaceuticals
CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained in the API used to manufacture the product.
Mylan Pharmaceuticals
CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained in the API used to manufacture the product.